Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Acumen Pharmaceuticals Inc
(NQ:
ABOS
)
2.390
+0.020 (+0.84%)
Streaming Delayed Price
Updated: 3:02 PM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acumen Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference
November 09, 2022
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
Acumen Pharmaceuticals to Report Third Quarter 2022 Financial Results on Nov. 14, 2022
November 07, 2022
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
Acumen Publishes Phase 1 Trial Design and Clinical Development Plan for ACU193, an Anti-Amyloid Beta Oligomer Antibody for Alzheimer’s Disease
November 01, 2022
Clinical development plan published in Journal of Prevention of Alzheimer’s Disease
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 24, 2022
Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The company's market cap stands at $26.3 million.
Via
Benzinga
Acumen’s ACU193, an Anti-Amyloid Beta Oligomer Antibody, Granted FDA Fast Track Designation for Alzheimer's Disease
October 24, 2022
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 12, 2022
Gainers
Via
Benzinga
How Is The Market Feeling About Acumen Pharmaceuticals?
October 12, 2022
Acumen Pharmaceuticals's (NASDAQ:ABOS) short percent of float has risen 237.39% since its last report. The company recently reported that it has 2.36 million shares sold short, which is 7.76% of all...
Via
Benzinga
RPM International, Lamb Weston And Some Other Big Stocks Moving Higher On Wednesday
October 05, 2022
U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Bank of America To $36? Plus This Analyst Slashes PT On Citigroup
October 05, 2022
Morgan Stanley cut Bank of America Corporation (NYSE: BAC) price target from $40 to $36. Bank of America shares fell 2.4% to $31.62 on Wednesday.
Via
Benzinga
Netflix, Biogen And Other Big Gainers From Wednesday
September 29, 2022
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Via
Benzinga
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...
Via
Benzinga
Nasdaq Surges Over 150 Points; Gold Rises 2%
September 28, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 28, 2022
Gainers
Via
Benzinga
Why Is Prothena (PRTA) Stock Up 75% Today?
September 28, 2022
Prothena (PRTA) stock is seeing massive gains on Wednesday despite a lack of recent news from the late-stage clinical company.
Via
InvestorPlace
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
September 28, 2022
Gainers
Via
Benzinga
Why Is Acumen (ABOS) Stock Up 95% Today?
September 28, 2022
Acumen Pharmaceuticals (ABOS) stock is rocketing higher on Wednesday but it's not due to any recent news from the company.
Via
InvestorPlace
Dow Jumps 300 Points; Crude Oil Rises Sharply
September 28, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Wednesday.
Via
Benzinga
Why Acumen Pharmaceuticals Stock Is Soaring Today
September 28, 2022
Acumen Pharmaceuticals Inc (NASDAQ: ABOS) shares are trading higher Wednesday after Biogen Inc (NASDAQ: BIIB) and Eisai Co (Pink:
Via
Benzinga
US Stocks Mixed; Wholesale Inventories Increase 1.3% In August
September 28, 2022
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 28, 2022
Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 28, 2022
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
Via
InvestorPlace
Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket
September 28, 2022
Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.
Via
Benzinga
Recap: Acumen Pharmaceuticals Q2 Earnings
August 15, 2022
Acumen Pharmaceuticals (NASDAQ:ABOS) reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
Via
Benzinga
Acumen Pharmaceuticals to Participate in Upcoming Investor and Scientific Conferences
July 26, 2022
From
Acumen Pharmaceuticals, Inc.
Via
GlobeNewswire
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
July 26, 2022
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022
July 15, 2022
Via
Benzinga
A Tale of Tangles Chapter Three: The Desert Expanse
April 28, 2022
Source: © Sergey Pesterev / Wikimedia Commons / CC BY-SA 4.0 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022
June 30, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.